Lisa Bjarkø
- PhD stipendiate, Consultant; MD
Publications 2025
Correction: Cardiac morphology in neonates with fetal growth restriction
J Perinatol, 45 (3), 416
DOI 10.1038/s41372-024-02104-0, PubMed 39256614
Publications 2024
Early postnatal transitional circulation in fetal growth restricted neonates
Early Hum Dev, 201, 106170
DOI 10.1016/j.earlhumdev.2024.106170, PubMed 39662237
Corrigendum to "Heart function by M-mode and tissue Doppler in the early neonatal period in neonates with fetal growth restriction", [Early Hum. Dev. 183 (2023) 105809]
Early Hum Dev, 194, 106032
DOI 10.1016/j.earlhumdev.2024.106032, PubMed 38763789
Publications 2023
Heart function by M-mode and tissue Doppler in the early neonatal period in neonates with fetal growth restriction
Early Hum Dev, 183, 105809
DOI 10.1016/j.earlhumdev.2023.105809, PubMed 37331046
Publications 2022
Cardiac morphology in neonates with fetal growth restriction
J Perinatol, 43 (2), 187-195
DOI 10.1038/s41372-022-01538-8, PubMed 36284207
Publications 2020
Adverse perinatal outcomes in 665,244 term and post-term deliveries-a Norwegian population-based study
Eur J Obstet Gynecol Reprod Biol, 247, 212-218
DOI 10.1016/j.ejogrb.2020.02.028, PubMed 32146227
Publications 2015
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009
Eur Addict Res, 21 (5), 253-61
DOI 10.1159/000381670, PubMed 25967268
Publications 2013
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants
Acta Paediatr, 102 (11), 1060-6
DOI 10.1111/apa.12378, PubMed 23909865
Publications 2012
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009
Drug Alcohol Depend, 127 (1-3), 200-6
DOI 10.1016/j.drugalcdep.2012.07.001, PubMed 22841456